Unboosted versus boosted atazanavir for reducing morbidity and mortality in people with HIV/AIDS

摘要

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To determine whether unboosted atazanavir‐containing regimens are more effective and safe than boosted atazanavir‐containing regimens in reducing morbidity and mortality in people living with HIV/AIDS.